Pharmaceutical Economics & Health PolicyEmergency hospital admissions after income-based deductibles and prescription copayments in older users of inhaled medications
References (32)
- et al.
The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: A systematic review of randomized placebo-controlled trials
Am J Med.
(2002) - et al.
Impact of two sequential drug cost-sharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthma
Clin Ther.
(2006) - et al.
Levalbuterol compared to racemic albuterol: Efficacy and outcomes in patients hospitalized with COPD or asthma
Chest.
(2003) - et al.
Adapting a clinical comorbidity index for use with ICD-9 CM administrative data: Differing perspectives
J Clin Epidemiol.
(1993) Drug insurance utilization management policies and “reference pricing”: An illustrated commentary on the article by Vittorio Maio and colleagues
Milbank Q.
(2005)- et al.
Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes
N Engl J Med.
(1991) - et al.
Adverse events associated with prescription drug cost-sharing among poor and elderly persons
JAMA.
(2001) - et al.
Income-based drug benefit policy: Impact on receipt of inhaled corticosteroid prescriptions by Manitoba children with asthma
CMAJ.
(2001) - et al.
Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors
N Engl J Med.
(2002) - et al.
Impact of reference-based pricing of nitrates on the use and costs of anti-anginal drugs
CMAJ.
(2001)
Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers
Clin Pharmacol Ther.
Impact of reference-based pricing for histamine-2 receptor antagonists and restricted access for proton pump inhibitors in British Columbia
CMAJ.
Clinical and economic consequences of a reimbursement restriction of nebulised respiratory therapy in adults: Direct comparison of randomised and observational evaluations
BMJ.
The effect of incentive-based formularies on prescription-drug utilization and spending
N Engl J Med.
Effect of a three-tier prescription copay on pharmaceutical and other medical utilization
Med Care.
Three-tieredcopayment drug coverage and use of nonsteroidal anti-inflammatory drugs
Arch Intern Med.
Cited by (30)
Disparities in Disease Burden and Treatment of Patients Asthma and Chronic Obstructive Pulmonary Disease
2022, Medical Clinics of North AmericaCitation Excerpt :High-deductibles were also associated with higher ER and hospital utilization among those with COPD in one cross-sectional national US-based study.46 Another analysis similarly found an increase in admissions for airway disease after the introduction of higher drug cost-sharing in the province of British Columbia.50 While these sorts of cost-barriers may serve to reduce care for patients with COPD in general, they could contribute to disparities in lung health for 2 reasons.
Associations of health services utilization by prescription drug coverage and immigration category in Ontario, Canada
2021, Health PolicyCitation Excerpt :This variation results in coverage gaps for some Canadians, leaving them uninsured if they are ineligible for public drug plans, cannot afford private insurance and, if employed, do not have an employer-provided plan. In Canada, studies reveal that without timely access to prescribed medications, a disease may progress to an acute level resulting in an increased likelihood of adverse health outcomes and the use of more expensive secondary health services [16,58]. Migrant populations are more likely than those born in Canada to be uninsured for prescription drugs [27].
National Trends and Disparities in Health Care Access and Coverage Among Adults With Asthma and COPD: 1997-2018
2021, ChestCitation Excerpt :A 2018 statement from the American Thoracic Society outlined the harms to patients stemming from high pharmaceutical costs.25 Exposure to high out-of-pocket health care costs has been associated with less inhaler use26 and more hospitalizations among adults with obstructive lung disease3,14 and more ED visits15 and exacerbations13 among children with asthma. It seems likely that persistent gaps in coverage and health care access faced by lower-income and minority groups contribute to contemporary inequities in COPD and asthma outcomes.
Assessing the Effectiveness of Policies to Reduce Diabetes Hospitalizations Before and After the Reforms of Physician Payment and Primary Care Organization in British Columbia and Alberta
2016, Canadian Journal of DiabetesCitation Excerpt :Most studies of PharmaCare suggest that the program had the potential to improve financial equity without affecting drug utilization significantly (31–33). However, 1 study that examined the potential effects on preventable hospitalizations of seniors associated the income-based deductible with higher emergency hospitalizations for seniors using inhaled medications for chronic pulmonary disease, asthma or emphysema (34). Alberta did not introduce any changes to its drug program during the period of the study (31).